Systematic Review: Screening
Identification
Screening
Eligibility
Included
Efficacy and Safety of RSVPreF Vaccine in Older Adults: Phase 3 RENOIR Trial Results
Walsh EE, Perez Marc G, Zareba AM, et al. — New England Journal of Medicine (2023)
Real-World Effectiveness of RSV Vaccination Among Medicare Beneficiaries, 2023-2024
Surie D, Bonnell L, Adams K, et al. — MMWR Morbidity and Mortality Weekly Report (2024)
ACIP Recommendations for RSV Vaccination in Adults Aged 60 Years and Older
Melgar M, Britton A, Roper LE, et al. — CDC Advisory Committee on Immunization Practices (2024)
Burden of RSV-Associated Hospitalizations Among US Adults, 2019-2023
Havers FP, Whitaker M, Melgar M, et al. — Clinical Infectious Diseases (2024)
Reason: Epidemiology only — no vaccine effectiveness data
Study team discussion: Data source selection and feasibility notes
Study team — Internal (2025)
Reason: Internal notes — not primary literature
Want to make screening decisions?
Sign up for free to unlock all features.